Table 3.
Variable | Overall (N=466)
|
High level of education a (N=188)
|
Low level of education b (N=278)
|
Males (N=156)
|
Females (N=310)
|
|||||
---|---|---|---|---|---|---|---|---|---|---|
HR (95% CI) c | P Value | HR (95% CI) c | P Value | HR (95% CI) c | P Value | HR (95% CI) c | P Value | HR (95% CI) c | P Value | |
Mortality | ||||||||||
High level of education (Ref: low level of education) | 1.76 (0.84–3.70) | 0.13 | NA | NA | NA | NA | 1.26 (0.25 – 6.39) | 0.78 | 1.57 (0.65 – 3.77) | 0.32 |
Males (Ref: females) | 1.53 (0.73 – 3.22) | 0.26 | 1.69 (0.55 – 5.21) | 0.36 | 1.61 (0.56 – 4.67) | 0.38 | NA | NA | NA | NA |
Baseline CD4+ count (by 50 cells/mm3 decrease) | 1.34 (0.98 – 1.83) | 0.06 | 1.85 (1.07 – 3.17) | 0.03 | 1.01 (0.67 – 1.52) | 0.96 | 1.37 (0.76 – 2.48) | 0.30 | 1.32 (0.91 – 1.93) | 0.15 |
Baseline WHO stage 4 HIV infection | 2.72 (1.28 – 5.74) | 0.01 | 3.06 (1.19 – 7.92) | 0.02 | 2.57 (0.68 – 9.80) | 0.17 | 8.77 (1.87 – 41.06) | 0.01 | 1.96 (0.74 – 5.18) | 0.17 |
Sustained Immunologic Response d | ||||||||||
High level of education (Ref: low level of education) | 1.03 (0.78 – 1.37) | 0.82 | NA | NA | NA | NA | 1.16 (0.64 – 2.11) | 0.62 | 0.99 (0.72 – 1.38) | 0.97 |
Males (Ref: females) | 0.66 (0.48 – 0.91) | 0.01 | 0.74 (0.44 – 1.26) | 0.27 | 0.63 (0.42 – 0.94) | 0.02 | NA | NA | NA | NA |
Baseline CD4+ count (by 50 cells/mm3 decrease) | 0.90 (0.82 – 1.00) | 0.05 | 0.87 (0.72 – 1.05) | 0.14 | 0.92 (0.81 – 1.04) | 0.16 | 0.87 (0.74 – 1.02) | 0.09 | 0.92 (0.81 – 1.04) | 0.19 |
Baseline WHO stage 4 HIV infection | 1.18 (0.78 – 1.79) | 0.42 | 1.07 (0.58 – 1.95) | 0.83 | 1.42 (0.80 – 2.52) | 0.23 | 1.10 (0.42 – 2.88) | 0.84 | 1.20 (0.75 – 1.91) | 0.44 |
Abbreviations: HR (Hazard Ratio); Ref (Reference); WHO (World Health Organization); NA (Not Applicable)
High level of education refers to those individuals who have completed secondary school or attended college or university.
Low level of education refers to those individuals who have primary school or less or some secondary school.
Multivariate model adjusted for the following factors (in addition to variables listed in table): age, occupation, number of children, past history of TB, Karnofsky score, baseline viral load
Immunologic response was defined as a sustained CD4+ ≥ 200 cells/mm3 from 6 months post-ARV initiation.